In summary, in this study, we demonstrated that AKF-D52 exerts its anticancer effects via intracellular ROS production and NF-κB activation, resulting in apoptotic cell death via intrinsic and extrinsic apoptotic pathways and cytoprotective autophagy in NSCLC cells. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.